Platelet BioGenesis Raises $26 Million

Related Posts

09Jun

On a roll: Wasabi gets $25m dollop for cloud storage three weeks after fishing out $122m

Less than a month after pulling in $122m in C-round funding, object storage firm Wasabi has opened its pockets again,... read more
20Dec

Walmart’s 2016 holiday videos on YouTube have earned over 75M views – Insight from Pixability

Walmart’s push on YouTube this holiday season is paying off, earning the brand more than 75 million video views for... read more
29Jan

OpenText goes retail with Carbonite acquisition

Carbonite is a well-known cloud security provider, and the endpoint security side of its operation came from the acquisition of... read more
29Jun

Vanguard Partners With Candidly For Student Loan Repayment Program

"Vanguard has partnered with Candidly to offer retirement plan sponsors a student loan debt repayment program option for eligible employees.... read more
14Nov

Robotic Arm Changes Life Of Stroke Survivor

This revolutionary technology was developed at the Massachusetts Institute of Technology and the device was created at the Cambridge-based start-up,... read more
12Apr

A single celled replacement for fishmeal?

Large scale production of a single cell organism could reduce the need to use wild-caught fish and agricultural crops as... read more
10Dec

Legally blind Canadian using electronic glasses to develop more accessible apps

...Through the Canadian National Institute for Blindness’ (CNIB) scholarship program, Pope has been awarded the eSight 4, a wearable medical... read more
29Jun

3Derm Teledermatology System to Partner with WoundRounds®

3Derm, an innovation leader in teledermatology, today announced a partnership with WoundRounds®, a service of Telemedicine Solutions, LLC (Schaumburg, IL).... read more
23May

Blind woman sees dog for the first time

Mary Sedgwick, who says she has been legally blind since 2003 due to bilateral optic neuritis, recently got the chance... read more
20Dec

Corbus Readies Pivotal Phase 3 Trial of Anabasum, Possible Scleroderma Treatment

Corbus Pharmaceuticals is planning a global Phase 3 trial to assess anabasum (JBT-101) as a treatment for scleroderma. If successful,... read more